Delivery Order SPE2DB22D2006-SPE2DB24FW1NF

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEPPRA 500 mg tablets. The contract has a ceiling value of $10,453.67 and a performance period through June 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 750 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $13,586.96 and a completion date of July 9, 2025. The contract is a firm fixed-price delivery order and is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,409.35 firm fixed-price delivery order is for the supply of KEPPRA 500 MG TABLET 120S, a medication, to support military healthcare programs. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $81,267.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 1,000 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of March 27, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,965.54, is for the supply of KEPPRA 500 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order, has no set-aside designation, and has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The delivery order is for the pharmaceutical product Keppra 250 mg tablet, with a ceiling value of $1,861.87 and an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide this critical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Keppra 1,000 mg tablets. The contract has a ceiling value of $7,792.24 and an ultimate completion date of November 28, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 500 MG TABLET 120S, a neurological medication, with a ceiling value of $5,539.44 and a performance period through June 10, 2025. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Keppra 1,000 mg tablets. The contract has a ceiling value of $12,577.01 and a completion date of April 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,291.56 firm fixed-price delivery order contract is for the supply of KEPPRA 750 MG TABLET 120S, a medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1NF
    Delivery Order

This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4565047090 - KEPPRA 500 MG TABLET 120S. The contract has a ceiling value of $10,723.98 and a period of performance through July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not designated as a set-aside and represents a small portion of the company's broader federal contracting portfolio with the Department of Defense and other agencies.

Generated 5/17/25, 10:10 AM